Celebrating Successful Members of the 1960s Debre Zeit:
In this part of the web site, we present the highlights of some of the distinguished citizens who graduated from high school in Debre Zeit in 1970 and their offspring. This group have experienced all the unique events and interesting features of Debre Zeit. For instance, this group have rebled against an elitist classroom assignment experiment where bright students were to be collected into one or two classrooms based on their reading ability; the first to be thought all subjects in Amharic in grade 5; take a national exam at grade six level. Before this group, national level exam was only conducted at grade 8 and grade 12 level. The grade 12 matriculation is required for admission to university.
While the most important asset of a place is its people, what the place offers can also impact the outcome of its citizens. Considering the state of the library, availability of books, state of science laboratory, Like the other Debre Zeit students before and after them, one can say the success of the 1970 graduate cohort is against all odds. One can say Debre Zeit is magical!
As a start, despite: limited number of schools; inadequate books; almost nonexistence of science laboratory; far distance students must travel to get to school; diversity of background of the population, especially urban and rural students, and not so high economic status of most of the families; it is a magic that a high proportion of the students succeeded.
Hence, Debre Zeit has contributed more than its fair share of successful people like Dr. Tebabu Tessema Wubetu and his friends. Some of the high achievers are highlighted below:
Dr. Tebabu Tessema Wubetu: Distinguished Obstetrician and Genecologist and Consultant in Industrial Medicine
Dr. Tebabu Tessema Wubetu attended elementary and Secondary schools at Atse Libnedingle elementary and Princess Tenagnework Secondary School (P.T.S.S) respectively. He graduated from high school with Great Distinction and enrolled in Haile Selassie I University (currently Addis Ababa University) during the 1970-71 academic year.
His academic achievements of great distinction have enabled him to win a one-year scholarship and a hand watch engraved with the name of the late Emperor from the Haile Selassie Awards for Excellence Organization.
After completing his freshman year at the Science Faculty at Arat Kilo Campus, in 1972 he was accepted by the medical school and commenced his medical training at the Prince Mekonnen Hospital now called the Black Lion Specialized Referral Hospital managed by the Addis Ababa University.
Following the 1974 political upheaval and subsequent campaign of red terror that was unleashed by the Socialist Military Regime (Derg), he was forced to join the armed struggle with the Ethiopian Peoples’ Revolutionary Party to establish democracy in Ethiopia.
Dr. Tebabu Tessema Wubetu was re-settled in the United Kingdom. In the United Kingdom, he resumed his medical training and in 1985 completed and registered to practice Medicine as obstetrician & gynecologists. Based on his distinguished work, Dr. Tebabu Tessema Wubetu's was elected as a Fellow of the Royal Physicians (FRCP) in 1990.
After a distinguished serves in his specialty, Dr. Tebabu Tessema Wubetu became a consultant in industrial medicine. In this new specialty, he extended his brilliant service until he retired in 2020.
He remained active in retirement serving as the founding chairman of Newcastle and surrounding area Ethiopian community; member of United Ethiopians for Peace and Reconciliation; as well as Director with the Northern Learning Trust.
Honoring his many years of outstanding and dedicated service, the Ethiopian community of Newcastle awarded Dr. Tebabu Tessema Wubetu a special honorary certificate.
Sadly Dr. Tebabu Tessema Wubetu unexpectedly and untimely passed away on November 30, 2021. He is dearly missed by all. This website is one of the ways in which we keep him alive.
Dr. Admassu Abebe: Distinguished Industrial Pharmacist and Inventor
Dr Admassu Abebe is born in Debre Zeit. He attended elementary and High school in Debre Zeit. He completed his high school with Distinction in Debre Zeit in 1970. He attended Addis Abeba University and graduated from school of pharmacy with great distinction. He obtained his master's degree from England and completed his P.H.D in Industrial Pharmacy from University of Grenoble, France
Dr. Admassu Abebe is a Senior Principal Scientist at Bristol-Myers Squibb based in New York City, New York.
Patents and Publications by Inventor Dr. Admassu Abebe
Patent number: 9616028b
Abstract: The present invention relates to bilayer tablet formulations comprising metformin extended release (XR) or reduced mass metformin XR formulation as the first layer, an SGLT2 inhibitor formulation as the second layer, and optionally a film coating. The present invention provides methods of preparing the bilayer tablet formulations and methods of treating diseases or disorders associated with SGLT2 activity employing the bilayer tablet formulations.
Filed: May 7, 2015. Type: Grant. Date of Patent: April 11, 2017
Assignees: AstraZeneca AB, AstraZeneca UK Limited
Inventors: Admassu Abebe, Kyle Martin, Jatin M. Patel, Divyakant Desai, Peter Timmins
Bilayer tablet formulations
Patent number: 9050258
Abstract: The present invention relates to bilayer tablet formulations comprising metformin extended release (XR) or reduced mass metformin XR formulation as the first layer, an SGLT2 inhibitor formulation as the second layer, and optionally a film coating. The present invention provides methods of preparing the bilayer tablet formulations and methods of treating diseases or disorders associated with SGLT2 activity employing the bilayer tablet formulations.
Type: Grant. Filed: August 13, 2013. Date of Patent: June 9, 2015
Assignee: AstraZeneca AB
Inventors: Admassu Abebe, Kyle Martin, Jatin M. Patel, Divyakant Desai, Peter Timmins
Bilayer tablet formulations
Patent number: 8535715
Abstract: The present invention relates to bilayer tablet formulations comprising metformin extended release (XR) or reduced mass metformin XR formulation as the first layer, an SGLT2 inhibitor formulation as the second layer, and optionally a film coating. The present invention provides methods of preparing the bilayer tablet formulations and methods of treating diseases or disorders associated with SGLT2 activity employing the bilayer tablet formulations.
Type: Grant. Filed: November 12, 2010. Date of Patent: September 17, 2013.
Assignees: Bristol-Myers Squibb Company, AstraZeneca UK Limited
Inventors: Admassu Abebe, Kyle Martin, Jatin M. Patel, Divyakant Desai, Peter Timmins
Dr. Admassu Abebe's research Publications:
Dr. Admassu Abebe's research while affiliated with Bristol-Myers Squibb and other places.
Number of Publications: 21
Few Examples:
Article: Evolution of the microstructure during the process of consolidation and bonding in soft granular solids, Feb 2016.
Authors: Bereket Yohannes, Gonzalez, Abebe[...], Alberto M Cuitiño
Abstract: The evolution of microstructure during powder compaction process was investigated using a discrete particle modeling, which accounts for particle size distribution and material properties, such as plasticity, elasticity, and inter-particle bonding. The material properties were calibrated based on powder compaction experiments and validated based on...
Article: The role of fine particles on compaction and tensile strength of pharmaceutical powders, Apr 2015.
Authors: Bereket Yohannes, Gonzalez, Abebe[...], Alberto M Cuitiño
Abstract: The role of fine particles on compaction of powders and the resultant compact was studied experimentally. Samples of powders were prepared by successively removing fine particles from microcrystalline cellulose and lactose monohydrate powders. This method of preparing samples is unique compared to previous studies on particle size distribution, and...
Article: Review of Bilayer Tablet Technology, Dec 2013.
Authors: Admassu Abebe, Ilgaz Akseli, Omar Sprockel[...], Alberto M Cuitiño
Abstract: Therapeutic strategies based on oral delivery of bilayer (and multilayer) tablets is gaining more acceptance among brand and generic products due to a confluence of factors including advanced delivery strategies, patient compliance and combination therapy. Successful manufacturing of these ever more complex systems needs to overcome a series of cha...
Article: Axial strength test for round flat faced versus capsule shaped bilayer tablets, Nov 2013.
Authors: Jason Franck, Admassu Abebe, Rekha Keluskar[...], Howard Stamato
Abstract: There has been increasing interest in fixed dose combination (FDC) therapy. Multi-layer tablets are a popular choice among various technologies to deliver FDCs. In most cases, round flat faced tooling is used in testing tablets as they have the simplest geometry. However, shaped tooling is more common for commercial products and may have a...
Conference Paper: The Use of Foam in High Shear Wet Granulation: Effect of Scale up On Granules Quality Attributes, Nov 2010
Authors: Niranjan Kottala, Admassu Abebe, Faranak Nikfar[...], Robert Jerzewski
Abstract: High shear wet granulation is a common pharmaceutical unit operation for forming agglomerates. The API under study offered challenges during processing due to its low bulk density, low particle size, and its adhesive nature when in contact with water. To address the above challenges a new granulation process was employed whereby liquid binders are...
Dr. Taddesse Gebregiorgis: Distinguished Polymer Chemist and Inventor
Dr. Taddesse was born and raised in Debre Zeit. He is one of the graduates of Prince Tenagework High school in 1970 in Debre Zeit. His educational background includes: Bachelor of Science (BS) Organic Chemistry, The American University in Cairo, Egypt; PH.D Polymer Chemistry University of Essex, England; and Post Doctoral Fellowship Polymer Chemistry University of Grenoble, France
Dr. Taddesse was a Senior Research Associate with a demonstrated history of working in the chemicals industry. Skilled in Research and Development (R&D), Chemistry, Life Sciences, Polymers, and Organic Chemistry.
Patents and Inventions by Dr. Taddesse Gebregiorgis:
Anti-corrosion electrocoat
Patent number: 10358735
Abstract: The present disclosure relates to the application of anti-corrosion coatings for a ferrous substrate. The first coating applied to the ferrous substrate is an electrocoat composition comprising electrically conductive pigments. A dried a cured coating layer of the first electrocoat composition provides the basis for a second electrocoat composition.
Filed: May 23, 2012. Type: Grant. Date of Patent: July 23, 2019
Assignee: Axalta Coating Systems IP Co., LLC
Inventor: Taddesse Gebregiorgis
Method for using 3-coat-1-bake waterborne coating composition
Patent number: 9903021
Abstract: Disclosed herein is a method to apply waterborne primer, basecoat and clearcoat compositions in a wet-on-wet manner followed by the curing of all three applied compositions to form a durable protective coating on a substrate. The primer composition comprises (meth)acrylic latex, polyurethane resin, melamine and, optionally, polyesters.
Filed: December 29, 2009. Type: Grant. Date of Patent: February 27, 2018
Assignee: AXALTA COATINGS SYSTEMS IP CO., LLC
Inventors: Taddesse Gebregiorgis, Donald Albert Paquet, Jr.
Organic solvent free pigment dispersant for waterborne electrocoating
Patent number: 8236157
Abstract: A pigment dispersing resin is disclosed along with pigment dispersion, electrodepositable coating compositions using the pigment dispersing resin, and methods for applying the electrodepositable coating composition. The pigment dispersing resin consists essentially of the carboxylic acid salt of an aminated bisphenol epoxy resin and an alkoxylated styrenated phenol. Pigment dispersions made from the dispersing resin are especially useful for forming low or no volatile organic content electrocoating baths.
Filed: December 12, 2008. Type: Grant. Date of Patent: August 7, 2012
Assignee: E I du Pont de Nemours and Company
Inventor: Taddesse Gebregiorgis
Cathodic electrodeposited coatings having high lubricity
Patent number: 6114040
Abstract: Self-lubricating is provided for cathodic electrodeposited coatings by including in the coating bath fine particles of polytetrafluoroethylene that have been milled with a cationic polyepoxide resin.
Filed: September 9, 1998. Type: Grant. Date of Patent: September 5, 2000
Assignee: E. I. du Pont de Nemours and Company
Inventors: Taddesse Gebregiorgis, Kathleen S. Shields, John Joseph Vincent
Pigment dispersant for cathodic electrocoating compositions
Patent number: 5324756
Abstract: A pigment dispersant that is useful in a cathodic electrocoating composition is prepared by bringing into contact the following compounds: a cyclic alkylene urea amine, a polyepoxide and a dialkanol amine; this pigment dispersant has an advantage of allowing for the high pigment to binder ratios and minimizes the volatile organic content (VOC) in the electrocoating composition.
Filed: May 5, 1993. Type: Grant. Date of Patent: June 28, 1994.
Assignee: E. I. Du Pont de Nemours and Company
Inventor: Taddesse Gebregiorgis
Imidazoline amine-epoxy adduct as a pigment dispersant
Patent number: 5128393
Abstract: A pigment dispersant useful in cathodic electrocoat compositions is disclosed. The pigment dispersant is the reaction product of an organic monoepoxide or polyepoxide with a primary amine containing an imidazoline moiety. This pigment dispersant allows the maximazation of pigment to binder ratios and the minimization of volatile organic content (VOC) in electrocoat baths.
Filed: June 11, 1991. Type: Grant. Date of Patent: July 7, 1992.
Assignee: E. I. Du Pont de Nemours and Company
Inventors: Stephen C. Peng, Taddesse Gebregiorgis
Pigment dispersant resin: reaction product of imidazoline and alkylene carbonate adduct and a half blocked diisocyanate
Patent number: 5116903
Abstract: A pigment dispersant that is useful in a cathodic electrocoating composition is prepared by bringing into contact compound (i), an alkylene carbonate, with a compound (ii) of the structure: ##STR1## where R is and alkyl group .having 8-24 carbon atoms, and bringing the resulting reaction product of (i) and (ii) into contact with a half blocked organic diisocyanate; this pigment dispersant has an advantage of allowing for the maximization of pigment to binder ratios and the minimization of volatile organic content (VOC) in electrocoating compositions.
Filed: April 5, 1991. Type: Grant. Date of Patent: May 26, 1992.
Assignee: E. I. Du Pont de Nemours & Co.
Inventor: Taddesse Gebregiorgis
Pigment dispersant resin: reaction product of imidazoline amine and alkylene carbonate
Patent number: 4946507
Abstract: A pigment dispersant useful in cathodic electrocoat compositions is disclosed. This pigment dispersant is the reaction product of alkylene carbonate and a primary amine containing an imidazoline moiety. This pigment dispersant allows the maximazation of pigment to binder ratios and the minimization of volatile organic content (VOC) in electrocoat baths.
Filed: July 12, 1989. Type: Grant. Date of Patent: August 7, 1990
Assignee: E. I. Du Pont de Nemours and Company
Inventors: Stephen C. Peng, Taddesse Gebregiorgis
Professor Dr. Brook Lemma Mamaru: Distinguished Freshwater Ecologist and Fishery Expert.